Medical detox and treatment programs focus on: Stabilizing the body safely Managing withdrawal symptoms with oversight Supporting sleep, nutrition, and mental health Medications like: Buprenorphine Methadone Naltrexone Have strong evidence showing they: Reduce cravings Lower overdose risk Improve long-term outcomes Sleep and stress, which DSIP targets, are also addressed through: Structured care Therapy Medication when appropriate Routine and stabilization A Better Way to Look at It DSIP is interesting from a research perspective

Check with your doctor immediately if any of the following side effects occur: More common Stomach pain Less common Difficulty in breathing or swallowing fast heartbeat gaseous stomach pain heartburn recurrent fever skin itching, rash, or redness stomach fullness swelling of the face, throat, or tongue vomiting yellow eyes or skin Incidence not known Anxiety bloating blurred vision chest tightness chills cold sweats confusion constipation cool, pale skin cough darkened urine depression dizziness fast heartbeat fever indigestion large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs loss of appetite nausea nervousness pains in the stomach, side, or abdomen, possibly radiating to the back puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue Shakiness unusual tiredness or weakness Some side effects may occur that usually do not need medical attention

Rats tolerated doses far exceeding those used therapeutically without mortality or obvious adverse effects
These seem to be the mechanisms by which ROS participate in the induction of low-grade chronic inflammation, cellular dysfunction, and implicitly in the promotion and aggravation of chronic conditions (e.g., cardiovascular, pulmonary, renal, metabolic, neurological, malignancies) ( Regarding kidney damage, OS is correlated in the literature with both antioxidant depletion and excessive ROS production, serving as both a cause and an effect of renal degradation